Header Logo

Connection

Timothy VanWagoner to Humans

This is a "connection" page, showing publications Timothy VanWagoner has written about Humans.
Connection Strength

0.259
  1. CATCH-UP vaccines: protocol for a randomized controlled trial using the multiphase optimization strategy (MOST) framework to evaluate education interventions to increase COVID-19 vaccine uptake in Oklahoma. BMC Public Health. 2023 06 14; 23(1):1146.
    View in: PubMed
    Score: 0.049
  2. The modA10 phasevarion of nontypeable Haemophilus influenzae R2866 regulates multiple virulence-associated traits. Microb Pathog. 2016 Mar; 92:60-67.
    View in: PubMed
    Score: 0.029
  3. Sex Differences in Long COVID. JAMA Netw Open. 2025 Jan 02; 8(1):e2455430.
    View in: PubMed
    Score: 0.027
  4. Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study. Clin Microbiol Infect. 2024 Dec; 30(12):1599-1605.
    View in: PubMed
    Score: 0.027
  5. Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort. Ann Intern Med. 2024 Sep; 177(9):1209-1221.
    View in: PubMed
    Score: 0.026
  6. Toward trustworthy COVID-19 interventions: Building vaccine trust through community-university partnerships. PLoS One. 2024; 19(3):e0300872.
    View in: PubMed
    Score: 0.013
  7. Validation of remote anthropometric measurements in a rural randomized pediatric clinical trial in primary care settings. Sci Rep. 2024 Jan 03; 14(1):411.
    View in: PubMed
    Score: 0.013
  8. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. PLoS One. 2023; 18(6):e0286297.
    View in: PubMed
    Score: 0.012
  9. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023 06 13; 329(22):1934-1946.
    View in: PubMed
    Score: 0.012
  10. Best Practices for Conducting Clinical Trials With Indigenous Children in the United States. Am J Public Health. 2021 09; 111(9):1645-1653.
    View in: PubMed
    Score: 0.011
  11. Identification of a siderophore utilization locus in nontypeable Haemophilus influenzae. BMC Microbiol. 2010 Apr 15; 10:113.
    View in: PubMed
    Score: 0.005
  12. Characterization of the Haemophilus influenzae tehB gene and its role in virulence. Microbiology (Reading). 2010 Apr; 156(Pt 4):1188-1200.
    View in: PubMed
    Score: 0.005
  13. The heme-binding protein (HbpA) of Haemophilus influenzae as a virulence determinant. Int J Med Microbiol. 2009 Nov; 299(7):479-88.
    View in: PubMed
    Score: 0.005
  14. Catalase as a source of both X- and V-factor for Haemophilus influenzae. FEMS Microbiol Lett. 2008 Feb; 279(2):157-61.
    View in: PubMed
    Score: 0.004
  15. Lipoprotein e (P4) of Haemophilus influenzae: role in heme utilization and pathogenesis. Microbes Infect. 2007 Jul; 9(8):932-9.
    View in: PubMed
    Score: 0.004
  16. Burkholderia cenocepacia utilizes ferritin as an iron source. J Med Microbiol. 2006 Jun; 55(Pt 6):661-668.
    View in: PubMed
    Score: 0.004
  17. Utilization of myoglobin as a heme source by Haemophilus influenzae requires binding of myoglobin to haptoglobin. FEMS Microbiol Lett. 2006 May; 258(2):235-40.
    View in: PubMed
    Score: 0.004
  18. Differential utilization by Haemophilus influenzae of haemoglobin complexed to the three human haptoglobin phenotypes. FEMS Immunol Med Microbiol. 2006 Apr; 46(3):426-32.
    View in: PubMed
    Score: 0.004
  19. Identification of an RTX determinant of Burkholderia cenocepacia J2315 by subtractive hybridization. J Med Microbiol. 2006 Jan; 55(Pt 1):11-21.
    View in: PubMed
    Score: 0.004
  20. Identification of a haem-utilization protein (Hup) in Haemophilus influenzae. Microbiology (Reading). 2004 Dec; 150(Pt 12):3923-33.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.